Novartis

International Novartis Bets Big on Cholesterol Drug With $9.7 Billion Buyout of Medicines Co.
BYJames Paton and Bloomberg
November 25, 2019
Newsletters The Fallout from Novartis’ Alleged Data Manipulation: Brainstorm Health
BYSy Mukherjee
August 14, 2019
Health Novartis Defends $2.1 Million Gene Therapy After FDA Data Manipulation Claims—Brainstorm Health
BYSy Mukherjee
August 6, 2019
Leadership Novartis CEO: It’s Time to “Pivot Towards Transformational Innovation”
BYSusie Gharib
March 20, 2019
Net Drug Prices Are Falling, Even as List Prices Increase
BYRenae Reints
January 30, 2019
Canadian Pot Firm Tilray Goes Global With Novartis Marijuana Deal
BYBloomberg
December 18, 2018
Health Why Cancer Biotech Allogene Just Scored an Eye Popping $324 Million IPO
BYSy Mukherjee
October 11, 2018
Health Drug Giant Novartis Is Temporarily Backing Off Price Increases Following Trump Pressure
BYSy Mukherjee
July 19, 2018
Health Novartis Is Spinning Off Its Alcon Eye Care Business and Launching a $5 Billion Share Buyback
BYSy Mukherjee
June 29, 2018

Most Popular